Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

PaperCitations, authors & open-access status

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 682 citations, 2013 year and green oa status.

682
Citations
2013
Year
green
OA Status

Related on ScholarIQ

Lin Wu
Author
Blood
Journal
Lymphoma Diagnosis and Treatment
Topic
Lymphoma Diagnosis and Treatment
Topic
CAR-T cell therapy research
Topic
Chronic Lymphocytic Leukemia Research
Topic
470M+ articles · free account